Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Environ Technol ; 39(11): 1368-1375, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28488938

ABSTRACT

In this study, the capability of using aerobic granules to undergo simultaneous anaerobic decolorization and aerobic aromatic amines degradation was demonstrated for azo dye wastewater treatment. An integrated acclimation-granulation process was devised, with Mordant Orange 1 as the model pollutant. Performance tests were carried out in a batch column reactor to evaluate the effect of various operating parameters. The optimal condition was to use 1.0-1.7 mm (1.51 ± 0.33 mm) granules, 5 g/L biomass, and 4000 mg/L organics as nutrient; and supplement the wastewater with 1  mg/L dissolved oxygen. This led to a dye mineralization of 61 ± 2%, an anaerobic dye removal of 88 ± 1%, and an aerobic aromatic amines removal of 70 ± 3% within 48 h. This study showed that simultaneous anaerobic/aerobic process by aerobic granules could be a possible alternative to the conventional activated sludge process.


Subject(s)
Azo Compounds/chemistry , Sewage/chemistry , Waste Disposal, Fluid , Amines , Bacteria, Aerobic , Bacteria, Anaerobic , Bioreactors , Coloring Agents , Wastewater
2.
Comput Chem Eng ; 33(5): 1097-1113, 2009 May 21.
Article in English | MEDLINE | ID: mdl-32287504

ABSTRACT

An integrative approach, involving marketing and management issues on the business side, and product design and prototyping on the technical side, is proposed for the development of chemical-based products. For the former, objective-time chart, RAT2IO modules and workflow diagrams are used for project management. For the latter, the integration of experiments, modeling and synthesis expedites product conceptualization and prototyping. Tasks for which chemical engineers are expected to play a key or a supporting role are discussed. An industrial application - the development of a skin-care cream is described alongside the procedure in order to illustrate the myriad issues in product development. In addition to the traditional engineering problems such as process and equipment design, product characterization, performance evaluation, and stability tests are also included as an integral part of this approach.

3.
Lab Invest ; 87(7): 644-50, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17384664

ABSTRACT

Aberrant activation of the wingless-type- (Wnt)-signaling pathway is common in many cancers including nasopharyngeal (NPC) and esophageal squamous cell (ESCC) carcinomas, both prevalent in Southern China and Southeast Asia. However, the molecular mechanism leading to this abnormality is still obscure. Wnt inhibitory factor-1 (WIF1) is a secreted antagonist of the Wnt pathway, and is recently shown to be inactivated by epigenetic mechanism in some tumors. Here, we examined whether WIF1 is also inactivated epigenetically in NPC and ESCC. With semiquantitative reverse transcription-PCR and methylation-specific PCR, we detected WIF1 downregulation or silencing in 6/6 of NPC and 12/19 of ESCC cell lines, which is well correlated with its methylation status. Methylation was further confirmed by high-resolution bisulfite genomic sequencing. Methylation was also frequently observed in a large collection of primary tumors of NPC (85%, 55/65) and ESCC (27%, 25/92), with WIF1 expressed and unmethylated in normal NPC and esophageal cell lines and normal tissues. Treatment of 5-aza-2'-deoxycytidine demethylated WIF1 and induced its expression in NPC and ESCC cell lines, highlighting a direct role of epigenetic inactivation. Ectopic expression of WIF1 in NPC and ESCC tumor cells resulted in significant inhibition of tumor cell colony formation, similar to TP53, and also significant downregulation of beta-catenin protein level in NPC cells. Thus, WIF1 functions as a tumor suppressor for both NPC and ESCC through suppressing the Wnt-signaling pathway, but is frequently silenced by epigenetic mechanism in a tumor-specific way. Our study indicates that epigenetic inactivation of WIF1 contributes to the aberrant activation of Wnt pathway and is involved in the pathogenesis of both tumors. WIF1 methylation could also serve as a specific biomarker for these tumors.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Carcinoma/genetics , DNA Methylation , Esophageal Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Nasopharyngeal Neoplasms/genetics , Repressor Proteins/metabolism , Tumor Suppressor Proteins/metabolism , Adaptor Proteins, Signal Transducing/drug effects , Adaptor Proteins, Signal Transducing/genetics , Animals , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Biomarkers, Tumor , Carcinoma/metabolism , Carcinoma/pathology , Cell Line , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Methylation/drug effects , Decitabine , Down-Regulation , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Gene Silencing , Humans , Nasopharyngeal Neoplasms/metabolism , Nasopharyngeal Neoplasms/pathology , Promoter Regions, Genetic/genetics , Repressor Proteins/drug effects , Repressor Proteins/genetics , Tumor Suppressor Proteins/drug effects , Tumor Suppressor Proteins/genetics , Wnt1 Protein/genetics , Wnt1 Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL